Abstract
Recurrent laryngeal papillomatosis is a benign disease of the larynx often leading to organic and functional restrictions. The therapeutic treatment of choice in larynx-obstructing papillomatosis is at present surgical laser ablation. The effectiveness of adjuvant intralesional injection of the virustaticum Cidofovir has been investigated recently in a variety of therapeutic models. The present case study deals with the treatment of recurrent laryngeal papillomatosis by means of surgical laser ablation of the laryngeal papillomas with adjuvant local injection of the virustaticum Cidofovir (dose of 5 mg/1 ml). Within the period from October 2001 to August 2004, ten patients aged between 5- and 70 years were treated with intralesional injections of Cidofovir. Papillomatosis was confirmed histologically in all cases, and the virus types were defined in part. Each of the patients underwent clinical–phoniatric examinations and was photographed for documentation. After 2–7 treatments with surgical laser papilloma ablation and intralesional Cidofovir injections, all patients showed a definite papilloma reduction, while in six cases complete remission was achieved. During the follow-up period of 8–30 months, not a single recurrence of the laryngeal papillomatosis occurred. In the majority of patients, a clear improvement in the voice was achieved. There were no local or systemic side effects caused by the virustaticum. Intralesional injection of Cidofovir is an adjuvant, but not a curative therapeutic option in recurrent laryngeal papillomatosis. Remission of previously frequently recurrent laryngeal papillomas can be achieved, but recurrence after longer treatment-free intervals is also possible.
Similar content being viewed by others
References
Akst LM, Lee W, Discolo C, Knott D, Younes A, Koltai PJ (2003) Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 129(8):841–846
Armstrong L, Derkay CS, Reeves WC, Task Force RRP (1999) Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 125:743–748
Avidano MA, Singleton GT (1995) Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 112(2):197–202
Bielamowicz S, Villagomez V, Stager SV, Wilson WR (2002) Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 112(4):696–699
Boltezar IH, Zargi M (2002) Laryngeal papillomatosis. ZDRAV VESTN 71(3):73–76
Cheville F (1994) Ultrastructural pathology. Iowa State University Press, Ames, 520
Chhetri DK, Shapiro NL (2003) A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 129(10):1081–1085
Dancey DR, Chamberlain DW, Krajden M, Palefsky J, Alberti PW, Downy GP (2000) Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature. Chest 118(4):1210–1214
Derkay CS (2001) Recurrent respiratory papillomatosis. Laryngoscope 111(1):57–69
Derkay CS, Darrow DH (2000) Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment. Otolaryngol Clin North Am 33(5):1127–1142
Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD (1998) A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 108(6):935–937
Erdamar B, Keles N, Kaur A (2002) Expression of the cyclin-kinase inhibitors p21 (WAF1) and p27(Kip1) and the p53 tumor supressor genes in adult—onset laryngeal papillomas. Eur Arch Otorhinolaryngol 259:516–520
Go C, Schwartz MR, Donocan DT (2003) Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 over-expression. Ann Otol Rhinol Laryngol 112:298–302
Lea AP, Bryson HM (1996) Cidofovir. Drugs 52 (2):225–230; discussion 231
Lele SM, Pou AM, Ventura K (2002) Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 126:1184–1188
Moore CE, Wiatrak BJ, McClatchey KD, Koopmann CF, Thomas GR, Bradford CR, Carey TE (1999) High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg 120(5):698–705
Naiman AN, Ceruse P, Coulombeau B, Froehlich P (2003) Intralesional cidofovir and surgical excision for laryngeal papillomatosis. Laryngoscope 113(12):2174–2181
Naiman AN, Roger G, Gagnieu MC, Bordenave J, Mathaut S, Ayari S, Nicollas R, Bour JB, Garabedian N, Froehlich P (2004) Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 114(7):1151–1156
Neumann K, Pudszuhn A, Welzel C, Bartel-Friedrich S, Passmann M (2003) Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results. Laryngol Rhinol Otol 82(10):700–706
Peyton S, Wiatrak W, Wiatrak B (2004) Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 68(4):413–418
Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO (1999) Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 125(10):1143–1148
Pransky SM, Brewster DF, Magit AE, Kearns DB (2000) Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126(10):1239–1243
Pransky SM, Albright JT, Magit AE (2003) Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 113(9):1583–1587
Ptok M, Schwemmle C, Iven C, Jessen M, Nawka T (2006) On the auditory evaluation of voice quality. HNO Mar, 46
Rehberg E, Kleinsasser O (1999) Malignant transformation in non-irradiated juvenile laryngeal papillomatosis. Eur Arch Otorhinolaryngol 256(9):450–454
Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK (1998) Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J 17(5):372–376
Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54(3):219–225
Snoeck R, Andrei G, De Clercq E (2001) Cidofovir in the treatment of HPV-associated lesions. Verh K Acad Geneeskd Belg 63(2):93–120
Stubenrauch F, Laimins LA (1999) Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 9(6):379–386
Van Cutsem E, Snoeck R, Van Ranst M, Fiten P, Opdenakker G, Geboes K, Janssens J, Rutgeerts P, Vantrappen G, De Clercq E (1995) Successful treatment of a squamous papilloma of the hypopharynx–esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J Med Virol 45(2):230–235
Wiatrak BJ (2003) Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg 11(6):433–441
Wilson WR, Hashemiyoon R, Hawrych A (2000) Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report. Ear Nose Throat J 79(4):236–238, 240
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was presented at the 5th ELS Congress in Lisbon, 10–13 July 2004
Rights and permissions
About this article
Cite this article
Pudszuhn, A., Welzel, C., Bloching, M. et al. Intralesional Cidofovir application in recurrent laryngeal papillomatosis. Eur Arch Otorhinolaryngol 264, 63–70 (2007). https://doi.org/10.1007/s00405-006-0151-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-006-0151-6